Process Subcommittee To Look To Europe For Technology Implementation
This article was originally published in The Tan Sheet
Executive Summary
FDA's Process Analytical Technology Subcommittee will look to European regulatory agencies and pharmaceutical firms to determine how to best implement new quality assurance manufacturing technology
You may also be interested in...
PAT Plus Three-Batch Validation Suggested As Transition Approach By FDA
Process analytical technologies (PAT) and conventional manufacturing validation methods could be implemented concurrently as a way to avoid product introduction delays during the transition to the new validation approach, FDA suggests
PAT Plus Three-Batch Validation Suggested As Transition Approach By FDA
Process analytical technologies (PAT) and conventional manufacturing validation methods could be implemented concurrently as a way to avoid product introduction delays during the transition to the new validation approach, FDA suggests
PAT Plus Three-Batch Validation Suggested As Transition Approach By FDA
Process analytical technologies (PAT) and conventional manufacturing validation methods could be implemented concurrently as a way to avoid product introduction delays during the transition to the new validation approach, FDA suggests